{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:36:08Z","timestamp":1790757368355,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009825","name":"American College of Radiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacr.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:45:32Z","timestamp":1772228732000},"page":"1183-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ACR Appropriateness Criteria\u00ae Demyelinating Diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"Aleks","family":"Kalnins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenora M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Soderlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinos","family":"Kontzialis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McMenamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashesh A.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Y.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2026.02.003_bib1","series-title":"Diseases of the brain, head and neck, spine 2020-2023: diagnostic imaging. Cham, Switzerland;","first-page":"165","article-title":"Demyelinating diseases of the CNS (brain and spine)","author":"Barkhof","year":"2020"},{"key":"10.1016\/j.jacr.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/1352458509105228","article-title":"Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis","volume":"15","author":"Klistorner","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jacr.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1586\/ern.11.16","article-title":"The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis","volume":"11","author":"Idiman","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jacr.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrneurol.2016.166","article-title":"The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative","volume":"12","author":"Sati","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1212\/WNL.0000000000005256","article-title":"Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD","volume":"90","author":"Cortese","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1352458520958589","article-title":"In vivo imaging of chronic active lesions in multiple sclerosis","volume":"28","author":"Calvi","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.jacr.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacr.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","article-title":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial","volume":"394","author":"Cree","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacr.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(20)30078-8","article-title":"Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial","volume":"19","author":"Traboulsee","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ana.26626","article-title":"Ravulizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"93","author":"Pittock","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clinimag.2014.10.014","article-title":"Longitudinal assessment of clinically isolated syndrome with diffusion tensor imaging and volumetric MRI","volume":"39","author":"Kolasa","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jacr.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.17219\/acem\/116754","article-title":"Diffusion tensor imaging of normal-appearing cervical spinal cords in patients with multiple sclerosis: correlations with clinical evaluation and cerebral diffusion tensor imaging changes. Preliminary experience","volume":"29","author":"Wolanczyk","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jacr.2026.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103127","article-title":"Functional connectivity in the dorsal network of the cervical spinal cord is correlated with diffusion tensor imaging indices in relapsing-remitting multiple sclerosis","volume":"35","author":"Combes","year":"2022","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jacr.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1177\/1352458517736148","article-title":"USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-up","volume":"24","author":"Kerbrat","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.jacr.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1109\/TMI.2016.2522178","article-title":"White matter MS-lesion segmentation using a geometric brain model","volume":"35","author":"Strumia","year":"2016","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.jacr.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00062-021-01089-z","article-title":"Assessment of artificial intelligence automatic multiple sclerosis lesion delineation tool for clinical use","volume":"32","author":"Hindsholm","year":"2022","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.jacr.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jon.12194","article-title":"Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors","volume":"25","author":"Dell'Oglio","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.jacr.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/RLI.0000000000000320","article-title":"Dynamic contrast-enhanced magnetic resonance imaging suggests normal perfusion in normal-appearing white matter in multiple sclerosis","volume":"52","author":"Ingrisch","year":"2017","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jacr.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-444-52001-2.00012-1","article-title":"MRI mimics of multiple sclerosis","volume":"122","author":"Aliaga","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.msard.2019.01.021","article-title":"Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease","volume":"29","author":"Salama","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jacr.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cei.13641","article-title":"Clinical and neuroimaging findings in MOGAD-MRI and OCT","volume":"206","author":"Bartels","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jacr.2026.02.003_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137715","article-title":"Imaging surrogates of disease activity in neuromyelitis optica allow distinction from multiple sclerosis","volume":"10","author":"Matthews","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacr.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacr.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000013016","article-title":"Performance of the 2017 and 2010 Revised McDonald Criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study","volume":"98","author":"Filippi","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jacr.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neurad.2020.01.083","article-title":"New OFSEP recommendations for MRI assessment of multiple sclerosis patients: special consideration for gadolinium deposition and frequent acquisitions","volume":"47","author":"Brisset","year":"2020","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.jacr.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1177\/13524585221118677","article-title":"Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis","volume":"28","author":"Meaton","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.jacr.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14737175.2023.2195095","article-title":"Current perspectives on the diagnosis and management of acute transverse myelitis","volume":"23","author":"Tisavipat","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jacr.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.jacr.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.nic.2024.03.002","article-title":"Routine MR imaging protocol and standardization in central nervous system demyelinating diseases","volume":"34","author":"Traboulsee","year":"2024","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.jacr.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/13524585241228426","article-title":"Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis","volume":"30","author":"Lim","year":"2024","journal-title":"Mult Scler"},{"key":"10.1016\/j.jacr.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14737175.2021.1982697","article-title":"Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review","volume":"21","author":"Lin","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jacr.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5603\/PJNNS.a2020.0084","article-title":"Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis","volume":"54","author":"Sasiadek","year":"2020","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.jacr.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.20344\/amp.20467","article-title":"[Use of gadolinium in follow-up MRI of multiple sclerosis patients: current recommendations]","volume":"37","author":"Cruz","year":"2024","journal-title":"Acta Med Port"},{"key":"10.1016\/j.jacr.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNO.0b013e318254c62d","article-title":"Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis","volume":"32","author":"Khanna","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jacr.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"S738","DOI":"10.1016\/j.jacr.2025.08.030","article-title":"Appropriateness Criteria\u00ae vision loss","volume":"22","author":"Friedman","year":"2025","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jacr.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.jacr.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00062-015-0430-y","article-title":"MRI in the diagnosis and monitoring of multiple sclerosis: an update","volume":"25","author":"Wattjes","year":"2015","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.jacr.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain-Barre syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacr.2026.02.003_bib42","series-title":"Measuring sex, gender identity, and sexual orientation","article-title":"Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Committee on National Statistics; Committee on Measuring Sex, Gender Identity, and Sexual Orientation. Measuring sex, gender identity, and sexual orientation","year":"2022"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144026000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144026000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:31:51Z","timestamp":1790393511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144026000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1546144026000633"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2026.02.003","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Demyelinating Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}